Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Dec 11, 2022 8:08pm
134 Views
Post# 35165108

RE:RE:RE:RE:Stern IR

RE:RE:RE:RE:Stern IRGreat question, beenthere. What did I do? What difference did I make?

Whether you make money or not all depends on the performance of Bioasis management and xB3, and the partners and pharmas to an extent. They're mules compareed to their xB3 load of wealth. The shareholders don't matter when it comes to success. Nor does Colwell Capital, Stern IR or me. 

If management performs and if the technology works, you couldn't keep investors away from this with a Gatling gun.

The only influence that I, GD and Stern might have is to affect your confidence in the story and its potential to create value for you. If you have confidence then you'll hold the stock until it is successful. But confidence doesn't make success. It anticipates success. However, confidence can cause a market to go up, the result of confident buying, investors chasing it, or shareholders simply refusing to sell, which gets back to IR influence. But in the end, xB3 has to work unless you get lucky and sell on a false run, and then it collapses forever.

The lack of confidence causes investors to sell. They then have no chance of further gains.

So if I created some confidence that has influenced you and others to hold, something for which I am criticized all the time on here, attacked for it, actually, and if Bioasis is successful then you'll make money. It's up to you to decide what my influence was.

All I can do is claim the work that I have done. In the case of Bioasis, I've have done an immense amount of work, too much of it unpaid, perhaps fraudulently.

It's all up to Bioasis, Dr. Deborah Rathjen, the BoD, the partners and pharmas and most of all, xB3.

I have nothing to do with success. I might have something to do with making you money.

Sadly, unless I'm paid, after all these years, I won't get anything out of it, but you never know what a good law firm might get out of it for me. We'll see. Fortunately, I have friends in low and high places.

jd
<< Previous
Bullboard Posts
Next >>